- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
Posted on 5/13/20 at 10:55 am to WaWaWeeWa
My response was already that a seemingly paradoxical impact on mortality is generally an indicator of poor study design or "Goldilocks" effect. The point of bringing up that particular analyses wasn't use it to assert support, but rather assert this study is not the "final nail in the coffin" of hcq that the media seems to think it is.
Shell seems to have an axe to grind with this study being debunked
Shell seems to have an axe to grind with this study being debunked
Posted on 5/13/20 at 10:57 am to WaWaWeeWa
quote:
I agree overall mortality is what we should be looking at. Unless there is a compelling argument otherwise.
True, but theres a hell of a selection bias in this study due to its observational nature.
Posted on 5/13/20 at 11:03 am to onmymedicalgrind
quote:
True, but theres a hell of a selection bias in this study due to its observational nature.
I will also go into detail on this since I know certain people will accuse my earlier response as a cop out.
It would make sense that overall mortality is higher in the Hcq group because there was a 40% difference in HTN prevalence and the control group is much younger.
If you look at just those who developed respiratory failure, it likely negates the recruitment bias because you probably have most of the old people/comorbid people.
ie. all the people who were at risk for deterioration, deteriorated, so the younger people without HTN in the control group are not included in the "respiratory failure" group by default.
99.6% of people under 40 are going to get better no matter what you do. The control group had 20% under 40, the tx group had 10%
"overall" statistics are almost useless in a study this bias.
This post was edited on 5/13/20 at 11:18 am
Posted on 5/13/20 at 11:49 am to Tiguar
quote:
but rather assert this study is not the "final nail in the coffin" of hcq that the media seems to think it is
Fair enough. I agree.
quote:
True, but theres a hell of a selection bias in this study due to its observational nature.
Absolutely. I mean the selection bias is so bad that even if the deaths in the hcq group were equal to the control group that’s a strong argument for it actually working
This post was edited on 5/13/20 at 11:52 am
Posted on 5/13/20 at 12:31 pm to Tiguar
My axe is with bullshite on any side of the argument. As I've already stated, the only thing this study shows is:
1) That we need randomized, controlled trials and
2) That the physicians at the hospital under study have a bias in who they are treating with HCQ.
I do not believe you can make any conclusions regarding the safety or efficacy of HCQ based on this study.
1) That we need randomized, controlled trials and
2) That the physicians at the hospital under study have a bias in who they are treating with HCQ.
I do not believe you can make any conclusions regarding the safety or efficacy of HCQ based on this study.
Posted on 5/13/20 at 12:41 pm to shell01
quote:
I do not believe you can make any conclusions regarding the safety or efficacy of HCQ based on this study.
And basically you can say that about any “study” conducted in the USA at this time. Academia has a huge liberal bias and I submit it is condescendingly showing. I am more readiy to believe the data coming in from France because they are not caught up in “OMB, must prove him wrong at any cost” and they are implementing the drugs much earlier (prior to intubation) which was the Initial intent....but due to politics/fear physicians are waiting until it is too late.
Posted on 5/13/20 at 12:57 pm to shell01
quote:
I do not believe you can make any conclusions regarding the safety or efficacy of HCQ based on this study.
Correct. Makes you really think why multiple news outlets were headlining this study as the "final nail in the coffin" for HCQ.
These news articles and headlines matter. Patients read them and decline therapy, or physicians read them and don't dig into the actual data and form a decision on hcq being "debunked".
This post was edited on 5/13/20 at 12:58 pm
Posted on 5/13/20 at 1:10 pm to Tiguar
Groups running many of these trials are companies trying to get their drugs through as a treatment. That doesn't bode well if an already available, generic and cheap treatment option that works exists.
Thus, they all rig their studies and its pathetic. It's embarrassing to be linked to that industry sometimes.
Thus, they all rig their studies and its pathetic. It's embarrassing to be linked to that industry sometimes.
Posted on 5/13/20 at 1:16 pm to Sasquatch Smash
quote:
Under patent for another 17 years...
And Gilead is one of the groups that ran trials on HCQ and claimed it was useless. Gee, I wonder why?
Seeing as Resdemivir was useless against pretty much all its target viruses, and now Gilead is trying to take advantage of the Pandemic to get a useless drug approved that has no business being approved. It's pathetic and unethical.
Posted on 5/13/20 at 1:29 pm to Geauxgurt
quote:
Gilead is one of the groups that ran trials on HCQ
link?
Popular
Back to top

0







